Comprehensive review on Alzheimer's Disease: Pathophysiology and its Treatment

Prativa Sadhu, S. Sen, Catherine Vanlalhriatpuii
{"title":"Comprehensive review on Alzheimer's Disease: Pathophysiology and its Treatment","authors":"Prativa Sadhu, S. Sen, Catherine Vanlalhriatpuii","doi":"10.54059/2021.4(3)crjpas_206","DOIUrl":null,"url":null,"abstract":"Neurodegenerative disorders are marked by the loss of brain neuron activity, resulting in gradual cognitive impairment. The effects of neurodegenerative diseases are severe in terms of pathology and the cost of patient care. The aged, in general, are the most vulnerable. Alzheimer's disease (AD) is a brain ailment that causes cell degradation and is the leading cause of dementia, identified by a loss of thinking ability and independence in daily tasks. The amyloid cascade hypothesis, which attributes clinical signs/symptoms to an abundance of amyloid-beta (Aβ) peptides, enhanced deposition into amyloid plaques, and eventually neuronal destruction, is one theory for pathogenesis AD. The use of acetylcholinesterase inhibitors in AD treatment is based on their favorable effects on the disease's functional, cognitive and behavioral symptoms. However, their involvement in AD pathogenesis is uncertain. This comprehensive review will provide an overview of AD, including the pathophysiology, causes, treatments, and future treatment.","PeriodicalId":131469,"journal":{"name":"Current Research Journal of Pharmaceutical and Allied Sciences","volume":"91 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Research Journal of Pharmaceutical and Allied Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.54059/2021.4(3)crjpas_206","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Neurodegenerative disorders are marked by the loss of brain neuron activity, resulting in gradual cognitive impairment. The effects of neurodegenerative diseases are severe in terms of pathology and the cost of patient care. The aged, in general, are the most vulnerable. Alzheimer's disease (AD) is a brain ailment that causes cell degradation and is the leading cause of dementia, identified by a loss of thinking ability and independence in daily tasks. The amyloid cascade hypothesis, which attributes clinical signs/symptoms to an abundance of amyloid-beta (Aβ) peptides, enhanced deposition into amyloid plaques, and eventually neuronal destruction, is one theory for pathogenesis AD. The use of acetylcholinesterase inhibitors in AD treatment is based on their favorable effects on the disease's functional, cognitive and behavioral symptoms. However, their involvement in AD pathogenesis is uncertain. This comprehensive review will provide an overview of AD, including the pathophysiology, causes, treatments, and future treatment.
阿尔茨海默病:病理生理学及其治疗的综合综述
神经退行性疾病的特征是大脑神经元活动的丧失,导致逐渐的认知障碍。神经退行性疾病的影响在病理和病人护理费用方面是严重的。一般来说,老年人是最脆弱的。阿尔茨海默病(AD)是一种导致细胞退化的脑部疾病,是痴呆症的主要原因,其特征是丧失思考能力和日常工作的独立性。淀粉样蛋白级联假说将临床体征/症状归因于淀粉样蛋白- β (Aβ)肽的丰富,淀粉样蛋白斑块沉积增强,最终神经元破坏,这是AD发病机制的一种理论。在AD治疗中使用乙酰胆碱酯酶抑制剂是基于它们对疾病的功能、认知和行为症状的有利作用。然而,它们在AD发病机制中的作用尚不确定。本文将对阿尔茨海默病的病理生理、病因、治疗和未来治疗进行综述。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信